Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Acro Biomedical's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0. The highest annual figure on record is $8.01M in fiscal 2018.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $658.50K | -45.0% |
| FY2021 | Dec 31, 2021 | $1.20M | -11.6% |
| FY2019 | Sep 30, 2019 | $1.35M | -83.1% |
| FY2018 | Sep 30, 2018 | $8.01M | +1471.5% |
| FY2017 | Sep 30, 2017 | $510.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $360.00K | -39.8% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $298.50K | +200.0% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $598.00K | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $500.00K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $99.50K | -92.7% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $0 | -100.0% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $0 | -100.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $0 | -100.0% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $1.35M | -6.3% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $2.41M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $2.20M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $1.96M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $1.45M | – |
See a number that looks wrong?